**Core Concept**
Halothane is a halogenated inhalational anesthetic agent that can cause malignant hyperthermia (MH) in susceptible individuals, particularly when co-administered with volatile anesthetics or depolarizing muscle relaxants like succinylcholine. This condition is characterized by a hypermetabolic state, muscle rigidity, and elevated body temperature.

**Why the Correct Answer is Right**
Malignant hyperthermia is triggered by the abnormal release of calcium ions from the sarcoplasmic reticulum, leading to sustained muscle contraction and rigidity. Succinylcholine, a depolarizing neuromuscular blocking agent, can further sensitize the muscle to the effects of halothane, increasing the risk of MH. The symptoms of MH include muscle stiffness, rigidity, and a rapid increase in body temperature.

**Why Each Wrong Option is Incorrect**
**Option A:** Malignant hyperthermia is not typically associated with the use of non-depolarizing muscle relaxants like vecuronium or rocuronium, which are not implicated in the pathogenesis of MH.
**Option B:** Myasthenia gravis is a neuromuscular disorder characterized by weakness and fatigue, rather than muscle rigidity and hyperthermia.
**Option C:** Status asthmaticus is a severe asthma exacerbation that can lead to respiratory failure, but it is not associated with muscle stiffness or malignant hyperthermia.

**Clinical Pearl / High-Yield Fact**
Malignant hyperthermia is a medical emergency that requires prompt recognition and treatment with dantrolene, a specific antidote that inhibits calcium release from the sarcoplasmic reticulum.

**Correct Answer:** C. Malignant hyperthermia.